HMGCR and metabolic disease: Collectively, these findings highlight the intricate regulatory network of HMGCR, SREBP-1c, SREBP-2, LDLR, FAS, and ACC in hepatic metabolism, identifying potential therapeutic nodes for metabolic disorders.